6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
18m ago	Pinnacle Silver and Gold Commences Trading on OTCQB
18m ago	Apogee Minerals Announces Non-Brokered Private Placement Financing
18m ago	Honey Badger Silver Closes Transformative Acquisition of the Important PC Silver Project in the Northwest Territories
19m ago	Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project
19m ago	Faraday Future Strategically Launches Its Embodied AI Developer Platform Purpose-Built for AI Natives, Marking 2026 as the Inaugural Year of EAI Robotics Education

About

Aardvark Therapeutics, Inc. Common Stock (NASDAQ:AARD) — investor relations, events, news, and company updates on 6ix.

Latest News

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aardvark Therapeutics Announces Leadership Appointments

Aardvark Therapeutics Announces Establishment of New U.S. Subsidiary to Support Development of Its Dermatology Pipeline; Bryan Jones Named Chief Executive Officer

Financials

Revenue

$0

Market Cap

$90.1 M

EPS

-2.93

Community Chat

Ask AI